NCT07162532View on ClinicalTrials.gov

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Not yet recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions
Chronic Lymphocytic Leukemia (CLL)
Interventions
DIAGNOSTIC_TEST

1 Complete blood picture (CBC) with blood film, lymphocytic count 2 and viral hepatitis 3 Immunophenotyping 4 LDH 5 Coomb's tests ,deletion 17p,IGVH mutation,ESR

Complete blood picture (CBC) with blood film, lymphocytic count 2 Routine liver and kidney function and viral hepatitis 3 Immunophenotyping 4 LDH 5 Coomb's tests 6 Erythrocyte sedimentation rate (ESR). 7 C reactive protein (CRP). 8 Cytogenetic profiles: del(17p) 9 molecular study :IGHV mutation status.

All Listed Sponsors
lead

Assiut University

OTHER

NCT07162532 - Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients | Biotech Hunter | Biotech Hunter